Helix BioPharma Corp
TSX:HBPView on OTC Pink - Current Information

  • LAST PRICE
    0.7000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.5600/ 4
  • Ask / Lots
    0.7700/ 10
  • Open / Previous Close
    --- / 0.7000
  • Day Range
    ---
  • 52 Week Range
    0.5000
    1.3500
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Yesterday

  • Nov 13, 2024

  • Nov 11, 2024

      Show headlines and story abstract

    • 12:01PM ET on Monday Nov 11, 2024 by Dow Jones
      Companies Mentioned: HBP

      November, 11, 2024 -- (Helix BioPharma Corp.) -- (TheNewswire)

      November 11, 2024 -- TheNewswire - Toronto, Ontario -- Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company), a clinical-stage biopharmaceutical company developing novel and unique therapies in the field of immuno-oncology, based on its proprietary technological CEACAM6 platform, DOS47, is pleased to announce that the Company attended the 15th World ADC San Diego from 4--7 November 2024, the world's leading and longest-standing forum on antibody-drug conjugates (ADCs).

  • Nov 8, 2024